Advertisement

Child's Nervous System

, Volume 34, Issue 11, pp 2321–2324 | Cite as

Rare childhood hybrid histiocytosis of the central nervous system—diagnosed by stereotactic brain biopsy with marked treatment response to clofarabine

  • J. Foss-SkiftesvikEmail author
  • D. Scheie
  • C. Klausen
  • A. Sehested
  • J. Skjøth-Rasmussen
Case Report

Abstract

Histiocytosis is a heterogeneous group of disease entities, comprised by two main categories, namely Langerhans and non-Langerhans cell histiocytoses. Central nervous system involvement in histiocytosis is considered very rare and is often secondary to affection of anatomically related bone structures and/or multi-organ disease. We present a never-before described case of rare childhood histiocytosis with hybrid features of Langerhans cell histiocytosis and juvenile xanthogranuloma confined to the central nervous system in a 2- and a half-year-old boy with distinct treatment response to clofarabine. The case also emphasizes the diagnostic significance of stereotactic brain biopsy.

Keywords

Histiocytosis Langerhans cell histiocytosis (LCH) Juvenile xanthogranuloma (JXG) Histiocytosis Central nervous system (CNS) Clofarabine 

Notes

Acknowledgements

We would like to acknowledge Dr. Jennifer Picarsic, Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center, for her important contribution to the pathological examination and diagnosis.

Compliance with ethical standards

Conflict of interest

On behalf of all authors, the corresponding author states that there are no conflicts of interest.

References

  1. 1.
    Jaffe R (2005) The diagnostic histopathology of Langerhans cell histiocytosis. In: Histiocytic disorders of children and adults. Basic Science, Clinical Features and Therapy. Cambridge University PressGoogle Scholar
  2. 2.
    Carstensen H, Ornvold K (1993) The epidemiology of LCH in children in Denmark, 1975–89. Med Pediatr Oncol 21:387–388Google Scholar
  3. 3.
    Grois N, Pötschger U, Prosch H, Minkov M, Arico M, Braier J, Henter JI, Janka-Schaub G, Ladisch S, Ritter J, Steiner M, Unger E, Gadner H, for the DALHX- and LCH I and II Study Committee (2006) Risk factors for diabetes insipidus in Langerhans cell histiocytosis. Pediatr Blood Cancer 46:228–233.  https://doi.org/10.1002/pbc.20425 CrossRefPubMedGoogle Scholar
  4. 4.
    Prayer D, Grois N, Prosch H, Gadner H, Barkovich AJ (2004) MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. AJNR Am J Neuroradiol 25:880–891PubMedGoogle Scholar
  5. 5.
    El DD, Young JL, De NJ et al (2015) Langerhans cell histiocytosis: a comprehensive review. Pathology 47:294–301.  https://doi.org/10.1097/PAT.0000000000000256 CrossRefGoogle Scholar
  6. 6.
    Grois N, Prayer D, Prosch H, Lassmann H (2005) Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain 128:829–838.  https://doi.org/10.1093/brain/awh403 CrossRefPubMedGoogle Scholar
  7. 7.
    Janssen D, Harms D (2005) Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry. Am J Surg Pathol 29:21–28CrossRefGoogle Scholar
  8. 8.
    Dehner LP (2003) Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol 27:579–593CrossRefGoogle Scholar
  9. 9.
    Chen W, Cheng Y, Zhou S, Chen Y, Chen X, Xia S (2017) Juvenile xanthogranuloma of central nervous system: imaging of two cases report and literature review. Radiol Infect Dis 4:117–120.  https://doi.org/10.1016/J.JRID.2017.08.009 CrossRefGoogle Scholar
  10. 10.
    Skjøth-Rasmussen J, Jespersen B, Brennum J (2015) The use of Brainsuite iCT for frame-based stereotactic procedures. Acta Neurochir 157:1437–1440.  https://doi.org/10.1007/s00701-015-2475-8 CrossRefPubMedGoogle Scholar
  11. 11.
    Simko SJ, Tran HD, Jones J, Bilgi M, Beaupin LK, Coulter D, Garrington T, McCavit TL, Moore C, Rivera-Ortegón F, Shaffer L, Stork L, Turcotte L, Welsh EC, Hicks MJ, McClain KL, Allen CE (2014) Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease. Pediatr Blood Cancer 61:479–487.  https://doi.org/10.1002/pbc.24772 CrossRefPubMedGoogle Scholar
  12. 12.
    Strehl JD, Stachel K-D, Hartmann A, Agaimy A (2012) Juvenile xanthogranuloma developing after treatment of Langerhans cell histiocytosis: case report and literature review. Int J Clin Exp Pathol 5:720–725PubMedPubMedCentralGoogle Scholar
  13. 13.
    Hoeger PH, Diaz C, Malone M, Pritchard J, Harper JI (2001) Juvenile xanthogranuloma as a sequel to Langerhans cell histiocytosis: a report of three cases. Clin Exp Dermatol 26:391–394CrossRefGoogle Scholar
  14. 14.
    Patrizi A, Neri I, Bianchi F, Guerrini V, Misciali C, Paone G, Burnelli R (2004) Langerhans cell histiocytosis and juvenile xanthogranuloma. Dermatology 209:57–61.  https://doi.org/10.1159/000078589 CrossRefPubMedGoogle Scholar
  15. 15.
    Pérez-Gala S, Torrelo A, Colmenero I, Contra T, Madero L, Zambrano A (2006) Juvenile multiple xanthogranuloma in a patient with Langerhans cell histiocytosis. Actas Dermosifiliogr 97:594–598CrossRefGoogle Scholar
  16. 16.
    Bains A, Parham DM (2011) Langerhans cell histiocytosis preceding the development of juvenile xanthogranuloma: a case and review of recent developments. Pediatr Dev Pathol 14:480–484.  https://doi.org/10.2350/10-12-0950-CR.1 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of NeurosurgeryRigshospitalet University HospitalCopenhagenDenmark
  2. 2.Department of NeuropathologyRigshospitalet University HospitalCopenhagenDenmark
  3. 3.Department of NeuroradiologyRigshospitalet University HospitalCopenhagenDenmark
  4. 4.Department of Paediatric OncologyRigshospitalet University HospitalCopenhagenDenmark

Personalised recommendations